EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression

Marloes Grobben iD, Margreet Bakker, Angela I Schriek, Liesbeth J J Levels, Jeffrey C Umotoy, Khadija Tejjani, Mariëlle J van Breemen, Ryan N Lin, Steven W de Taeye, Gabriel Ozorowski, Neeltje A Kootstra, Andrew B Ward und 6 weitere

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Marloes Grobben und 17 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Disease Progression, HIV-1, HIV Infections, HIV Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Amsterdam Institute of Infection and Immunity, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 infection leads to chronic disease requiring life-long treatment and therefore alternative therapeutics, a cure and/or a protective vaccine are needed. Antibody-mediated effector functions could have a role in the fight against HIV-1. However, the properties underlying the potential beneficial effects of antibodies during HIV-1 infection are poorly understood. To identify a specific profile of antibody features associated with delayed disease progression, we studied antibody polyfunctionality during untreated HIV-1 infection in the well-documented Amsterdam Cohort Studies. Serum samples were analyzed from untreated individuals with HIV-1 at approximately 6 months (n = 166) and 3 years (n = 382) post-seroconversion (post-SC). A Luminex antibody Fc array was used to profile 15 different Fc features for serum antibodies against 20 different HIV-1 envelope glycoprotein antigens and the resulting data was also compared with data on neutralization breadth. We found that high HIV-1 specific IgG1 levels and low IgG2 and IgG4 levels at 3 years post-SC were associated with delayed disease progression. Moreover, delayed disease progression was associated with a broad and polyfunctional antibody response. Specifically, the capacity to interact with all Fc γ receptors (FcγRs) and C1q, and in particular with FcγRIIa, correlated positively with delayed disease progression. There were strong correlations between antibody Fc features and neutralization breadth and several antibody features that were associated with delayed disease progression were also associated with the development of broad and potent antibody neutralization. In summary, we identified a strong association between broad, polyfunctional antibodies and delayed disease progression. These findings contribute new information for the fight against HIV-1, especially for new antibody-based therapy and cure strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionHIV-1HIV InfectionsHIV AntibodiesHumansMaleFemaleImmunoglobulin GCohort StudiesAdultAntibodies, NeutralizingReceptors, IgG

Substanzen

HIV AntibodiesImmunoglobulin GAntibodies, NeutralizingReceptors, IgG

Autor:innen und Institutionen

  • Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Amsterdam, The Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
  • The Scripps Research Institute, Department of Structural Biology and Computational Biology, La Jolla, California, United States of America.
  • Amsterdam UMC, location University of Amsterdam, Department of Experimental Immunology, Amsterdam, The Netherlands.
  • The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Department of Microbiology and Immunology, Melbourne, Australia.
  • Alfred Hospital and Central Clinical School, Monash University, Melbourne Sexual Health Centre and Department of Infectious Diseases, Melbourne, Australia.

ORCID-Profile: Marloes Grobben, Marit J van Gils

Förderung

  • Gates Foundation
  • Amsterdam Institute of Infection and Immunity
  • National Health and Medical Research Council
  • Amsterdam UMC
  • Netherlands Organization for Scientific Research
  • Bill and Melinda Gates Foundation
  • CAVD network

Zitieren

APA

Grobben, M., Bakker, M., Schriek, A. I., Levels, L. J. J., Umotoy, J. C., Tejjani, K., van Breemen, M. J., Lin, R. N., de Taeye, S. W., Ozorowski, G., Kootstra, N. A., Ward, A. B., Kent, S. J., Hogarth, P. M., Wines, B. D., Sanders, R. W., Chung, A. W., & van Gils, M. J. (2024). Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012739

Vancouver

Grobben M, Bakker M, Schriek AI, Levels LJJ, Umotoy JC, Tejjani K, et al. Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012739

BibTeX
@article{Grobben2024,
  author = {Grobben, Marloes and Bakker, Margreet and Schriek, Angela I and Levels, Liesbeth J J and Umotoy, Jeffrey C and Tejjani, Khadija and van Breemen, Mariëlle J and Lin, Ryan N and de Taeye, Steven W and Ozorowski, Gabriel and Kootstra, Neeltje A and Ward, Andrew B and Kent, Stephen J and Hogarth, P Mark and Wines, Bruce D and Sanders, Rogier W and Chung, Amy W and van Gils, Marit J},
  title = {Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012739}
}
Kostenlos starten →